Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 51-75 of 106 citing articles:

Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults in the United States
Hagit Kopel, Văn Hùng Nguyễn, Cathérine Boileau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system
Katia Bruxvoort, Lina S. Sy, Vennis Hong, et al.
Vaccine (2023) Vol. 41, Iss. 49, pp. 7460-7468
Open Access | Times Cited: 8
Effectiveness of mRNA-1273 bivalent (Original and Omicron BA.4/BA.5) COVID-19 vaccine in preventing hospitalizations for COVID-19, medically attended SARS-CoV-2 infections, and hospital death in the United States
Hung Fu Tseng, Bradley K. Ackerson, Lina S. Sy, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Reminders, but not monetary incentives, increase COVID-19 booster uptake
Tom Chang, Mireille Jacobson, Manisha Shah, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 31
Open Access | Times Cited: 7
The Effectiveness of Bivalent COVID-19 Vaccination: A Preliminary Report
Ssu-Yu Chen, Chien‐Yu Lin, Hsin Chi, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2094-2094
Open Access | Times Cited: 7
Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults
Nelson Lee, Lena Nguyen, Peter C. Austin, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 5, pp. 1372-1382
Open Access | Times Cited: 7
Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge
Lindsay Hill-Batorski, Richard A. Bowen, Helle Bielefeldt‐Ohmann, et al.
Vaccine (2024) Vol. 42, Iss. 11, pp. 2770-2780
Closed Access | Times Cited: 2
Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
Camilla Mattiuzzi, Giuseppe Lippi
Vaccines (2023) Vol. 11, Iss. 2, pp. 213-213
Open Access | Times Cited: 6
Laboratory-Confirmed COVID-19 Case Incidence Rates Among Residents in Nursing Homes by Up-to-Date Vaccination Status — United States, October 10, 2022–January 8, 2023
Heather Dubendris, Hannah E. Reses, Emily Wong, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 4, pp. 95-99
Open Access | Times Cited: 6
Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants
Michael J. Moser, Lindsay Hill-Batorski, Richard A. Bowen, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1063-1063
Open Access | Times Cited: 6
Impact of vaccination and non-pharmacological interventions on COVID-19: a review of simulation modeling studies in Asia
Karan Thakkar, Júlia Spinardi, Jingyan Yang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 6
Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study
Wataru Mimura, Chieko Ishiguro, Junko Terada-Hirashima, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 6
Bivalent Covid-19 Vaccines
Peter Marks, Robert M. Califf
New England Journal of Medicine (2023) Vol. 388, Iss. 12, pp. 1151-1152
Open Access | Times Cited: 5
Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults
Nelson Lee, Lena Nguyen, Peter C. Austin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort study
Jessica A. Breznik, Ahmad Rahim, Hina Bhakta, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Open Access | Times Cited: 5
Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions
Ruth Link‐Gelles, Amadea Britton, Katherine E. Fleming-Dutra
Vaccine (2023) Vol. 42, pp. 125492-125492
Open Access | Times Cited: 5
Dynamics of Anti-SARS-CoV-2 IgA and IgG Responses and Their Protective Effect against Fatal Disease after Booster COVID-19 Vaccination
Matthaios Speletas, Ioanna Voulgaridi, Zacharoula Bogogiannidou, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 12-12
Open Access | Times Cited: 4
Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines
George Kassianos, Pauline MacDonald, Ivan Dinesh Aloysius, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 57-57
Open Access | Times Cited: 1
Pediatric cancer patients vaccinated against SARS-CoV-2—a clinical and laboratory follow-up
Benjamin Siebald, Andreas H. Groll, Sarah Salou, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 4
Open Access | Times Cited: 1
Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study
Congqin Chen, Chunmei Chen, Longxing Cao, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112022-112022
Open Access | Times Cited: 1
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine
Shanti Pather, Nicola Charpentier, Frank van den Ouweland, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126165-126165
Open Access | Times Cited: 1
Effectiveness of bivalent mRNA booster vaccination and previous infection in older adults during Omicron period: real-world evidence
Pedro Pablo España, Idoia Castillo-Sintes, María José Legarreta, et al.
Age and Ageing (2024) Vol. 53, Iss. 11
Closed Access | Times Cited: 1
Adapted vaccine strategy: facing the persistent challenges of COVID-19
Lianhan Shang, Bin Cao
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 9, pp. 984-985
Open Access | Times Cited: 4
COVID-19 Infection Rates in Vaccinated and Unvaccinated Inmates: A Retrospective Cohort Study
L.K. Ko, Gary Malet, Lisa Chang, et al.
Cureus (2023)
Open Access | Times Cited: 3
Retrospective Analysis of Vaccination Status and Predominant Viral Variants in Patients Hospitalized with COVID-19 in Reus, Spain
Simona Iftimie, Ana F. López‐Azcona, Maria José Lozano‐Olmo, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 886-886
Open Access | Times Cited: 2

Scroll to top